Figure 3: Prognostic value of total eIF2α in breast cancer.
From: Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients
Kaplan–Meier survival curves of disease-free survival for (a) all patients, (b) patients with estrogen receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative disease, (c) patients with HER2-positive disease, (d) patients with estrogen receptor-negative/HER2-negative disease.
